Fujifilm Diosynth: Fujifilm Diosynth Biotechnologies completes expansion at Europe's largest end-to-end biopharmaceutical manufacturing site

Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, has completed its recent production expansion in Denmark. This first expansion for the site increases capacity from six to twelve bioreactors for mammalian cell culture, making the site the largest end-to-end biopharmaceutical manufacturing site in Europe. A [...] The post Fujifilm Diosynth Biotechnologies completes expansion at Europe's largest end-to-end biopharmaceutical manufacturing site appeared first on Chemical Engineering.